SLI
2.005,87
PKT
-4,87
PKT
-0,24
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 31.05.16 | Roche overweight | Morgan Stanley | |
| 31.05.16 | Novartis Underweight | Morgan Stanley | |
| 31.05.16 | Roche overweight | JP Morgan Chase & Co. | |
| 31.05.16 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.05.16 | UBS Neutral | JP Morgan Chase & Co. | |
| 27.05.16 | Nestlé overweight | JP Morgan Chase & Co. | |
| 27.05.16 | Givaudan Underweight | Barclays Capital | |
| 27.05.16 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 26.05.16 | Nestlé overweight | JP Morgan Chase & Co. | |
| 26.05.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 26.05.16 | UBS Hold | Deutsche Bank AG | |
| 26.05.16 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 25.05.16 | Holcim Neutral | JP Morgan Chase & Co. | |
| 25.05.16 | Nestlé Sell | Goldman Sachs Group Inc. | |
| 25.05.16 | Richemont buy | Goldman Sachs Group Inc. | |
| 24.05.16 | Richemont Outperform | Robert W. Baird & Co. Incorporated | |
| 24.05.16 | Richemont Neutral | Credit Suisse Group | |
| 24.05.16 | Richemont Underperform | Macquarie Research | |
| 24.05.16 | Richemont market-perform | Bernstein Research | |
| 24.05.16 | Swiss Re Neutral | UBS AG | |
| 23.05.16 | Richemont buy | Kepler Cheuvreux | |
| 23.05.16 | Richemont Hold | Société Générale Group S.A. (SG) | |
| 23.05.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 23.05.16 | Richemont Neutral | JP Morgan Chase & Co. | |
| 23.05.16 | Richemont Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.05.16 | Novartis Neutral | Citigroup Corp. | |
| 23.05.16 | Richemont Neutral | Citigroup Corp. | |
| 23.05.16 | Richemont buy | UBS AG | |
| 20.05.16 | UBS Neutral | JP Morgan Chase & Co. | |
| 20.05.16 | UBS Neutral | JP Morgan Chase & Co. | |
| 20.05.16 | Holcim neutral | Bernstein Research | |
| 19.05.16 | Zurich Insurance Verkaufen | Independent Research GmbH | |
| 19.05.16 | Richemont Outperform | BNP PARIBAS | |
| 19.05.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 19.05.16 | Holcim overweight | Morgan Stanley | |
| 19.05.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 19.05.16 | Roche overweight | JP Morgan Chase & Co. | |
| 19.05.16 | UBS Neutral | JP Morgan Chase & Co. | |
| 19.05.16 | UBS Neutral | JP Morgan Chase & Co. | |
| 19.05.16 | UBS buy | UBS AG |